Fexofenadine HCL Tablets

About Fexofenadine HCL Tablets

With the wealth of deep expertise in this domain, our firm is engaged in offering Fexofenadine HCL Tablets. These tablets are formulated in our hygienic and advanced facilities using premier-grade ingredients. Due to its special chemical characteristics, it is widely used for the treatment of allergy symptoms, hay fever, and urticaria. Besides, it is recommended by medical practitioners to cure the symptoms associated with seasonal allergic rhinitis as well as for the treatment of chronic urticaria. We offer Fexofenadine HCL Tablets to the clients in qualitative packaging and at affordable price range.

Salient features:

• Longer shelf life
• Purity
• Exact composition
• Safe to consume

Product details

Composition:

Each uncoated tablet contains :

Fexofenadine Hydrochloride BP ............. 120 mg

Excipients ..................................................... q.s.

Drug Description :

Fexofenadine hydrochloride, the active ingredient of FEXUME (Fexofenadine HCl) tablets, is a histamine H1-receptor antagonist.

Indications :

Seasonal Allergic Rhinitis

FEXUME (Fexofenadine HCl) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older.

Chronic Idiopathic Urticaria

FEXUME (Fexofenadine HCl) is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.

Dosage :

FEXUME (Fexofenadine HCl) tablets

Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria

Adults and Children 12 Years and Older : The recommended dose of FEXUME (Fexofenadine HCl) tablets is 60 mg twice daily or 120 mg once daily with water. A dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function.

Children 6 to 11 Years : The recommended dose of FEXUME (Fexofenadine HCl) tablets is 30 mg twice daily with water. A dose of 30 mg once daily is recommended as the starting dose in pediatric patients with decreased renal function.